Aurora Cannabis Inc. (ACB)
Stock Price Chart
Key Info
| Market Cap | 1.55B |
| Revenue (ttm) | 204.12M |
| Net Income (ttm) | -2.62B |
| Shares Out | 115.23M |
| EPS (ttm) | 0.22 |
| PE Ratio | 49.77 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | December 2 |
| Last Price | $10.95 |
| Previous Close | $9.75 |
| Change ($) | 1.20 |
| Change (%) | 12.31% |
| Day's Open | 10.15 |
| Day's Range | 9.85 - 11.39 |
| Day's Volume | 71,247,293 |
| 52-Week Range | 3.83 - 31.56 |
More Stats
| Market Cap | 1.55B |
| Enterprise Value | 1.81B |
| Earnings Date (est) | n/a |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 115.23M |
| Float | n/a |
| EPS (basic) | n/a |
| EPS (diluted) | 0.22 |
| FCF / Share | -3.97 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | 2.01% |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 41.22M |
| Short Ratio | 0.77 |
| Short % of Float | n/a |
| Beta | 1.59 |
| PE Ratio | 49.77 |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 7.58 |
| PB Ratio | 1.08 |
| Revenue | 204.12M |
| Operating Income | -342.77M |
| Net Income | -2.62B |
| Free Cash Flow | -457.98M |
| Net Cash | -258.20M |
| Net Cash / Share | -1.83 |
| Gross Margin | -22.33% |
| Operating Margin | -167.93% |
| Profit Margin | -1,282.20% |
| FCF Margin | -224.37% |
| ROA | -6.71% |
| ROE | -103.28% |
| ROIC | -201.10% |
Analyst Forecasts
Analyst Consensus: Hold
Financial Performance
Financial Overview
| Year | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|
| Revenue | 279 | 246 | 55.20 | 1.44 |
| Revenue Growth | 13.59% | 344.84% | 3735.72% | - |
| Gross Profit | -33.54 | 142 | 43.52 | 2.20 |
| Operating Income | -491 | -318 | -95.77 | -4.59 |
| Net Income | -3,366 | -320 | 63.81 | -5.72 |
| Shares Outstanding | 109 | 83.17 | 23.25 | 10.75 |
| Earnings Per Share | -33.94 | -3.66 | 1.80 | -0.48 |
| Operating Cash Flow | -338 | -192 | -81.67 | -6.77 |
| Capital Expenditures | -351 | -414 | -137 | -1.89 |
| Free Cash Flow | -689 | -606 | -219 | -8.66 |
| Cash & Equivalents | 182 | 369 | 149 | 0.26 |
| Total Debt | 531 | 645 | 203 | 10.49 |
| Net Cash / Debt | -350 | -276 | -53.84 | -10.23 |
| Assets | 2,784 | 5,499 | 1,887 | 18.40 |
| Liabilities | 657 | 1,112 | 334 | 12.43 |
| Book Value | 2,151 | 4,383 | 1,548 | 5.96 |
Company Profile
Company Details
| Full Name | Aurora Cannabis Inc. |
| Employees | 2,731 |
| CEO | Michael Singer |
Stock Information
| Ticker Symbol | ACB |
| Stock Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers-Specialty & Generic |
| Unique Identifier | NYSE: ACB |
Description
Aurora Cannabis produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.